Chapter/Section Purchase

Leave This Empty:

Global Transcriptomics Market Insights and Forecast to 2028

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transcriptomics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 PCR
1.2.3 Microarray
1.2.4 Sequencing
1.3 Market by Application
1.3.1 Global Transcriptomics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Transcriptomics Market Perspective (2017-2028)
2.2 Transcriptomics Growth Trends by Region
2.2.1 Transcriptomics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Transcriptomics Historic Market Size by Region (2017-2022)
2.2.3 Transcriptomics Forecasted Market Size by Region (2023-2028)
2.3 Transcriptomics Market Dynamics
2.3.1 Transcriptomics Industry Trends
2.3.2 Transcriptomics Market Drivers
2.3.3 Transcriptomics Market Challenges
2.3.4 Transcriptomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transcriptomics Players by Revenue
3.1.1 Global Top Transcriptomics Players by Revenue (2017-2022)
3.1.2 Global Transcriptomics Revenue Market Share by Players (2017-2022)
3.2 Global Transcriptomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transcriptomics Revenue
3.4 Global Transcriptomics Market Concentration Ratio
3.4.1 Global Transcriptomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transcriptomics Revenue in 2021
3.5 Transcriptomics Key Players Head office and Area Served
3.6 Key Players Transcriptomics Product Solution and Service
3.7 Date of Enter into Transcriptomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transcriptomics Breakdown Data by Type
4.1 Global Transcriptomics Historic Market Size by Type (2017-2022)
4.2 Global Transcriptomics Forecasted Market Size by Type (2023-2028)
5 Transcriptomics Breakdown Data by Application
5.1 Global Transcriptomics Historic Market Size by Application (2017-2022)
5.2 Global Transcriptomics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Transcriptomics Market Size (2017-2028)
6.2 North America Transcriptomics Market Size by Type
6.2.1 North America Transcriptomics Market Size by Type (2017-2022)
6.2.2 North America Transcriptomics Market Size by Type (2023-2028)
6.2.3 North America Transcriptomics Market Share by Type (2017-2028)
6.3 North America Transcriptomics Market Size by Application
6.3.1 North America Transcriptomics Market Size by Application (2017-2022)
6.3.2 North America Transcriptomics Market Size by Application (2023-2028)
6.3.3 North America Transcriptomics Market Share by Application (2017-2028)
6.4 North America Transcriptomics Market Size by Country
6.4.1 North America Transcriptomics Market Size by Country (2017-2022)
6.4.2 North America Transcriptomics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Transcriptomics Market Size (2017-2028)
7.2 Europe Transcriptomics Market Size by Type
7.2.1 Europe Transcriptomics Market Size by Type (2017-2022)
7.2.2 Europe Transcriptomics Market Size by Type (2023-2028)
7.2.3 Europe Transcriptomics Market Share by Type (2017-2028)
7.3 Europe Transcriptomics Market Size by Application
7.3.1 Europe Transcriptomics Market Size by Application (2017-2022)
7.3.2 Europe Transcriptomics Market Size by Application (2023-2028)
7.3.3 Europe Transcriptomics Market Share by Application (2017-2028)
7.4 Europe Transcriptomics Market Size by Country
7.4.1 Europe Transcriptomics Market Size by Country (2017-2022)
7.4.2 Europe Transcriptomics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transcriptomics Market Size (2017-2028)
8.2 Asia-Pacific Transcriptomics Market Size by Type
8.2.1 Asia-Pacific Transcriptomics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Transcriptomics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Transcriptomics Market Share by Type (2017-2028)
8.3 Asia-Pacific Transcriptomics Market Size by Application
8.3.1 Asia-Pacific Transcriptomics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Transcriptomics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Transcriptomics Market Share by Application (2017-2028)
8.4 Asia-Pacific Transcriptomics Market Size by Region
8.4.1 Asia-Pacific Transcriptomics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Transcriptomics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Transcriptomics Market Size (2017-2028)
9.2 Latin America Transcriptomics Market Size by Type
9.2.1 Latin America Transcriptomics Market Size by Type (2017-2022)
9.2.2 Latin America Transcriptomics Market Size by Type (2023-2028)
9.2.3 Latin America Transcriptomics Market Share by Type (2017-2028)
9.3 Latin America Transcriptomics Market Size by Application
9.3.1 Latin America Transcriptomics Market Size by Application (2017-2022)
9.3.2 Latin America Transcriptomics Market Size by Application (2023-2028)
9.3.3 Latin America Transcriptomics Market Share by Application (2017-2028)
9.4 Latin America Transcriptomics Market Size by Country
9.4.1 Latin America Transcriptomics Market Size by Country (2017-2022)
9.4.2 Latin America Transcriptomics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transcriptomics Market Size (2017-2028)
10.2 Middle East & Africa Transcriptomics Market Size by Type
10.2.1 Middle East & Africa Transcriptomics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Transcriptomics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Transcriptomics Market Share by Type (2017-2028)
10.3 Middle East & Africa Transcriptomics Market Size by Application
10.3.1 Middle East & Africa Transcriptomics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Transcriptomics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Transcriptomics Market Share by Application (2017-2028)
10.4 Middle East & Africa Transcriptomics Market Size by Country
10.4.1 Middle East & Africa Transcriptomics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Transcriptomics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Transcriptomics Introduction
11.1.4 Thermo Fisher Scientific Revenue in Transcriptomics Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Transcriptomics Introduction
11.2.4 Illumina Revenue in Transcriptomics Business (2017-2022)
11.2.5 Illumina Recent Developments
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Details
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Transcriptomics Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Transcriptomics Business (2017-2022)
11.3.5 QIAGEN (Exiqon) Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Transcriptomics Introduction
11.4.4 Agilent Technologies Revenue in Transcriptomics Business (2017-2022)
11.4.5 Agilent Technologies Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Transcriptomics Introduction
11.5.4 Roche Revenue in Transcriptomics Business (2017-2022)
11.5.5 Roche Recent Developments
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Transcriptomics Introduction
11.6.4 GE Healthcare Revenue in Transcriptomics Business (2017-2022)
11.6.5 GE Healthcare Recent Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Transcriptomics Introduction
11.7.4 Bio-Rad Laboratories Revenue in Transcriptomics Business (2017-2022)
11.7.5 Bio-Rad Laboratories Recent Developments
11.8 Fluidigm
11.8.1 Fluidigm Company Details
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm Transcriptomics Introduction
11.8.4 Fluidigm Revenue in Transcriptomics Business (2017-2022)
11.8.5 Fluidigm Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer